NCT03256162View on ClinicalTrials.gov

Ketamine as an Adjunctive Therapy for Major Depression

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 7, 2017

Primary Completion Date

September 21, 2018

Study Completion Date

September 21, 2018

Conditions
Major Depressive EpisodeUnipolar DepressionBipolar Depression
Interventions
DRUG

Ketamine

A sub-anaesthetic dose of ketamine will be administered in four infusions, each one week apart.

DRUG

Midazolam

A sub-anaesthetic dose of midazolam will be administered in four infusions, each one week apart.

Trial Locations (1)

D8

St Patrick's University Hospital, Dublin

All Listed Sponsors
lead

St Patrick's Hospital, Ireland

OTHER

NCT03256162 - Ketamine as an Adjunctive Therapy for Major Depression | Biotech Hunter | Biotech Hunter